Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis

Background. Myasthenia gravis is a chronic, autoimmune disease with muscle weakness. Acetylcholinesterase inhibitors are used in the symptomatic treatment of the disease. Allergic reaction to pyridostigmine bromide is rare. In the literature, no allergic reaction to pyridostigmine bromide has...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatih Kaplan, Erdem Topal
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2023-04-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/38
Tags: Add Tag
No Tags, Be the first to tag this record!